Loading clinical trials...
Loading clinical trials...
A Multi-Center, Open-Labelled, Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Conditions
Interventions
Pralatrexate
Locations
1
Taiwan
Ntional Taiwan University Hospital
Taipei, Taiwan
Start Date
August 30, 2016
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2020
Last Updated
May 12, 2017
NCT07389616
NCT07356245
NCT07353840
NCT04068597
NCT06072131
NCT04083495
Lead Sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions